Literature DB >> 19840883

Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study.

Paige Moorhouse1, Xiaowei Song, Kenneth Rockwood, Sandra Black, Andrew Kertesz, Serge Gauthier, Howard Feldman.   

Abstract

BACKGROUND AND
PURPOSE: The importance of executive dysfunction is increasingly recognized in the dementia syndrome. Although executive dysfunction has been associated with subcortical ischemic lesions, it may not be unique to VCI or to its clinical subtypes.
METHODS: Secondary analysis of the CIVIC study, a multi-centre memory clinic cohort study. An executive dysfunction index variable was created using 30 items from the clinical evaluation.
RESULTS: Of 1347 patients, 151 had a baseline diagnosis of no cognitive impairment (NCI), 463 had AD, 324 had VCI, 97 had vascular cognitive impairment not dementia (VCI-ND) and 253 had non-vascular CIND. Those with VCI and AD had higher mean executive dysfunction index values than those with NCI (F=160.2, p<0.01). Within the VCI subtypes, people with VaD and mixed dementia had the highest mean executive dysfunction index values (F=92.5, p<0.01). Higher executive dysfunction index values were significantly correlated with lower MMSE scores (R=0.70, p<0.01), higher Functional Rating Scale scores (R=0.77, p<0.01) and higher Geriatric Depression Score values (R=0.11, p<0.01). Compared to those who had a lower burden of executive dysfunction, patients with more executive dysfunction (index values >=0.2) were more likely to be institutionalized (HR=5.2, p<0.01) or to die (HR=2.4, p<0.01) during the next 30 months.
CONCLUSIONS: Executive dysfunction is common in both AD and VCI. It is associated with poor performance on other measures of cognition and function. The presence of executive dysfunction is associated with worse near-term outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19840883     DOI: 10.1016/j.jns.2009.09.017

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Early biomarkers for post-stroke cognitive impairment.

Authors:  Lai Qian; Lidong Ding; Liqun Cheng; Xiaolei Zhu; Hui Zhao; Jiali Jin; Dening Guan; Bing Zhang; Xuemei Chen; Yun Xu
Journal:  J Neurol       Date:  2012-03-10       Impact factor: 4.849

2.  Altered resting-state networks may explain the executive impairment in young health immigrants into high-altitude area.

Authors:  Xiaoming Chen; Jian Liu; Jiye Wang; Zhenlong Xin; Qian Zhang; Wenbin Zhang; Yibin Xi; Yuanqiang Zhu; Chen Li; Jiaming Li; Yuedong Han; Jie Liu; Baojuan Li; Wenjing Luo; Jingyuan Chen
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

3.  Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability.

Authors:  George S Alexopoulos; Patrick J Raue; Dimitris N Kiosses; R Scott Mackin; Dora Kanellopoulos; Charles McCulloch; Patricia A Areán
Journal:  Arch Gen Psychiatry       Date:  2011-01

4.  NIH EXAMINER: conceptualization and development of an executive function battery.

Authors:  Joel H Kramer; Dan Mungas; Katherine L Possin; Katherine P Rankin; Adam L Boxer; Howard J Rosen; Alan Bostrom; Lena Sinha; Ashley Berhel; Mary Widmeyer
Journal:  J Int Neuropsychol Soc       Date:  2013-10-08       Impact factor: 2.892

5.  Medial temporal atrophy and memory dysfunction in poststroke cognitive impairment-no dementia.

Authors:  Beom Joon Kim; Mi-Young Oh; Myung Suk Jang; Moon-Ku Han; Jisung Lee; Juneyoung Lee; Yeonwook Kang; Kyung-Ho Yu; Byung-Chul Lee; Sangyun Kim; Byung-Woo Yoon; Hee-Joon Bae
Journal:  J Clin Neurol       Date:  2012-03-31       Impact factor: 3.077

Review 6.  Vascular dementia: Cognitive, functional and behavioral assessment. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part II.

Authors:  Eliasz Engelhardt; Carla Tocquer; Charles André; Denise Madeira Moreira; Ivan Hideyo Okamoto; José Luiz de Sá Cavalcanti
Journal:  Dement Neuropsychol       Date:  2011 Oct-Dec

7.  Inhibitory Control, Task/Rule Switching, and Cognitive Planning in Vascular Dementia: Are There Any Differences From Vascular Aging?

Authors:  Krystallia Pantsiou; Ourania Sfakianaki; Vasileios Papaliagkas; Dimitra Savvoulidou; Vassiliki Costa; Georgia Papantoniou; Despina Moraitou
Journal:  Front Aging Neurosci       Date:  2018-10-17       Impact factor: 5.750

Review 8.  The role of inflammasomes in vascular cognitive impairment.

Authors:  Luting Poh; Wei Liang Sim; Dong-Gyu Jo; Quynh Nhu Dinh; Grant R Drummond; Christopher G Sobey; Christopher Li-Hsian Chen; Mitchell K P Lai; David Y Fann; Thiruma V Arumugam
Journal:  Mol Neurodegener       Date:  2022-01-09       Impact factor: 14.195

9.  Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial.

Authors:  Ihab Hajjar; Maureen Okafor; Darius McDaniel; Malik Obideen; Elizabeth Dee; Mahsa Shokouhi; Arshed A Quyyumi; Allan Levey; Felicia Goldstein
Journal:  JAMA Netw Open       Date:  2020-08-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.